Abstract.A polymerase chain reaction (PCR)-based detection assay that specifically detected Ehrlichia canis in dogs with acute infections was developed. A region of the 16S ribosomal RNA gene of E. canis was targeted for PCR amplification and chemiluminescent hybridization (CH) with a complementary internal 287-base pair (bp) oligonucleotide probe. The CH improved the PCR assay sensitivity 1,000-fold as compared with visualization on ethidium bromide-stained agarose gels. The PCR assay with CH (PCRKH) detected as little as 30 fg of E. canis genomic DNA, the equivalent of approximately 150 E. canis organisms. The 495-bp product defined by the specific primers was not detected when genomic DNA from E. platys, E. chaffeensis, E. risticii, and E. equi were used in the PCR/CH assay. The PCR/CH assay was tested with unfractionated blood samples collected from 9 dogs experimentally infected with E. canis. The PCR/CH assay had greater detection sensitivity than did cell culture isolation (CCI) from infected blood. PCR/CH detected E. canis 7 days prior to CCI in 4 of 6 experimentally infected dogs. The results obtained with the PCR/CH assay otherwise consistently matched the results obtained by CCI. This PCR/CH assay is a rapid, sensitive, and specific method for E. canis detection with sensitivity comparable to or exceeding that of CCI. A diagnosis of E. canis using this PCR/CH assay can be made in 2 days as compared with 14 weeks for CCI. The PCR/CH assay appears to be an acceptable alternative or complement to current diagnostic techniques.Canine ehrlichiosis is a tick-borne disease caused by an obligate intracellular parasite, Ehrlichia canis, which resides and replicates within mononuclear cells.7 The organism has a global distribution, including the United States, northern and southern African countries, Europe, Southeast Asia, and India.1,2,5-7 The association of E. canis with hemorrhagic disease in dogs was first described in 1969.8 Diagnosis of canine in the early stage of infection is important to ensure early treatment and a good prognosis.7 Dogs in the acute phase of the disease demonstrate dramatic improvement in hematologic and clinical responses 24-48 hours after therapy.7 However, dogs in the chronic stage of the disease have a poor prognosis and may not improve following treatment.
7,11Currently, definitive diagnosis of canine ehrlichiosis is based on hematologic, biochemical, and serologic findings.7 However, the most clinically reliable method for diagnosis of canine ehrlichiosis is by serologic techniques such as immunofluorescent antibody test (IFA) and plate latex agglutination that detect E. canis serum antibodies.7 However, serologic tests have several disadvantages: IgM and IgG antibodies are not detectable until at least 1-3 weeks postinfection, and cross-reactions occur between Ehrlichia species. Both of these factors can sometimes make a differential diagnosis difficult. Alternatively, the use of cell culture isolation (CCI) to detect E. canis in blood from infected dogs is both sensitive and ...